- Home
- EBF vs BCAX Comparison
EBF vs BCAX Comparison
Compare EBF & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBF
- BCAX
- Stock Information
- Founded
- EBF 1909
- BCAX 2018
- Country
- EBF United States
- BCAX United States
- Employees
- EBF N/A
- BCAX N/A
- Industry
- EBF Office Equipment/Supplies/Services
- BCAX
- Sector
- EBF Consumer Discretionary
- BCAX
- Exchange
- EBF Nasdaq
- BCAX NYSE
- Market Cap
- EBF 488.0M
- BCAX 541.0M
- IPO Year
- EBF N/A
- BCAX 2024
- Fundamental
- Price
- EBF $17.76
- BCAX $11.10
- Analyst Decision
- EBF
- BCAX Strong Buy
- Analyst Count
- EBF 0
- BCAX 7
- Target Price
- EBF N/A
- BCAX $29.17
- AVG Volume (30 Days)
- EBF 167.2K
- BCAX 647.6K
- Earning Date
- EBF 06-23-2025
- BCAX 08-16-2025
- Dividend Yield
- EBF 5.64%
- BCAX N/A
- EPS Growth
- EBF N/A
- BCAX N/A
- EPS
- EBF 1.51
- BCAX N/A
- Revenue
- EBF $388,707,000.00
- BCAX N/A
- Revenue This Year
- EBF $0.48
- BCAX N/A
- Revenue Next Year
- EBF N/A
- BCAX N/A
- P/E Ratio
- EBF $11.80
- BCAX N/A
- Revenue Growth
- EBF N/A
- BCAX N/A
- 52 Week Low
- EBF $17.15
- BCAX $7.80
- 52 Week High
- EBF $25.75
- BCAX $28.09
- Technical
- Relative Strength Index (RSI)
- EBF 39.96
- BCAX N/A
- Support Level
- EBF $17.53
- BCAX N/A
- Resistance Level
- EBF $18.45
- BCAX N/A
- Average True Range (ATR)
- EBF 0.34
- BCAX 0.00
- MACD
- EBF -0.07
- BCAX 0.00
- Stochastic Oscillator
- EBF 20.44
- BCAX 0.00
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialities, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360º Custom LabelsSM, ColorWorx, Enfusion, among others.
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.